We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

White knight

6 April 2011 By Chris Hughes

Activists seeking change at the Swiss pharma have won a small governance victory with the appointment of former GSK CEO JP Garnier as chairman designate. While it is not clear Garnier has the right ideas, it may now be harder for the activists’ board slate to win election.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)